USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Zora Biosciences OY

USPTO PatentsView assignee record - 25 granted patents across 11 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

RSS updates for this company

The verdict

According to USPTO PatentsView, Zora ranks #12,325 of 49,997 tracked US assignees by granted-patent volume, with 25 patents across 11 technology areas.

#12,325
of 49,997 US assignees by volume
Top 41%
by Innovation Score (38.5/100)
20.3
avg claims per patent
-62%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R12325 · Foreign Corporation #12,325 · 25 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-SMALL 25 grants
  • UPPER-Q #12,325/49,997
  • PHOTO-FINISH Xi'an University of…
  • CPC-FOCUS G01N · 11 areas
  • INNOV-THIN 38.5/100
  • CLAIMS-DENSE 20.3 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -62% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Xi'an University of Architecture and Technology (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Zora’s 38.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Zora

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Zora's Innovation Score is 38.5/100 (top 41% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Zora?

Each dot is one of Zora’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Zora’s own 20.3 claims/patent is ABOVE the 18.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Zora vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 24.924.92525.1 0510152025 Granted patents (volume) Avg claims / patent Xi'an University of Architecture and Technology - 25, 8.32Xi'an University…Xirrus, Inc. - 25, 17.96XirrusZenith Epigenetics Ltd. - 25, 18.36Zenith EpigeneticsZhejiang Jiecang Linear Motion Technology Co., Ltd. - 25, 9.56Zhejiang Jiecang…ZPE Systems, Inc. - 25, 17.96ZPE SystemsZendesk, Inc. - 25, 22.48ZendeskZero Friction, LLC - 25, 5.4Zero FrictionZipline Medical Inc. - 25, 22.48Zipline MedicalZora Biosciences OY - 25, 20.32Zora Biosciences…
Zora vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Zora's grants concentrate

Zora Biosciences OY is a focused PatentsView assignee: 11 CPC subclasses with 100% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2015 (4 grants) versus a trough of 1 in 2021. By volume, Zora sits between Xi'an University of Architecture and Technology and Zipline Medical Inc..

Zora's three-year grant acceleration

Zora Biosciences OY shows 3 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Zora's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Zora holds 25 patents at rank #12,317, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Zora

By rank, the assignees closest to #12,317 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Zora's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Zora, neither rank-band nor same-CPC leaders (those blocks stay above). In G01N (Investigating OR Analysing Materials BY Determining Their…), Zora ranks #601 of 7,863 assignees by patent count in that subclass.

Zora's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 41% higher than 59% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

012345 2015201620172018201920202021202220242025 3
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Zora Biosciences OY patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 4 16.0%
2016 4 16.0%
2017 3 12.0%
2018 2 8.0%
2019 3 12.0%
2020 2 8.0%
2021 1 4.0%
2022 1 4.0%
2024 2 8.0%
2025partial year 3 12.0%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Zora Biosciences OY's patent record in context - here's where to go next.

  • Zora Biosciences OY's lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 100% of its portfolio - see every assignee active in that class. Explore G01N
  • Ranked #12,325 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Zora Biosciences OY against Xi'an University of Architecture and Technology, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 38.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.